Split Creek Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$324K Sell
280
-163
-37% -$192K 0.31% 100
2026
Q2
$531K Buy
443
+49
+12% +$50.1K 0.49% 65
2026
Q1
$362K Buy
+394
New +$399K 0.38% 76

Other funds holding LLY

Split Creek Capital's LLY Position: Q3 2026 in Review

Split Creek Capital reduced its Eli Lilly (LLY) stake by 37% in Q3 2026, selling an estimated $192K and leaving 280 shares worth $324K. The position accounts for 0.31% of the portfolio, ranked #100.

Split Creek Capital first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $531K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Split Creek Capital held 280 shares of Eli Lilly worth $324K as of Q3 2026.
  • Split Creek Capital sold 163 Eli Lilly shares in Q3 2026, an estimated $192K.
  • Eli Lilly made up 0.31% of Split Creek Capital's portfolio in Q3 2026, its #100 holding.
  • Split Creek Capital first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Split Creek Capital's Eli Lilly position peaked at $531K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.